Skip to main content
Caplight Logo









Shanghai YaKe Biotechnology Co., Ltd.

Shanghai YaKe Biotechnology Co., Ltd.

Private
ShanghaiHealthcare & Life Scienceshttps://www.yakebiotech.net/

Last Round

Series A

May 1, 2016

Total Funding Raised

$1.53M

Company Overview

Shanghai YaKe Biotechnology Co., Ltd. is a biotechnology company that develops cancer immunotherapy technologies, specifically focusing on CAR-T cell therapies for B-cell malignancies and other blood cancers.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

CAR-T therapycellular immunotherapycell therapyhematological malignanciesdual-targeting CAR-Tcancer immunotherapybiotech R&Dclinical trialsengineered T-cellsautoimmune disease therapyprecision medicineoncology biotechnext-gen immunotherapycell manufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Shanghai YaKe Biotechnology Co., Ltd. Comparables

Compare Shanghai YaKe Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.

Shanghai YaKe Biotechnology Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PersonGen BioTherapeutics
89%
Shanghai Unicar-Therapy Bio-medicine Technology
88%
Shenzhen Pregene Bio-Pharmaceutical Co., Ltd.
87%

Shanghai YaKe Biotechnology Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMay 1, 2016

Shanghai YaKe Biotechnology Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

Shanghai YaKe Biotechnology Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Shanghai YaKe Biotechnology Co., Ltd.'s valuation, stock price, and market status.

Is Shanghai YaKe Biotechnology Co., Ltd. a public or private company?

Shanghai YaKe Biotechnology Co., Ltd. is a private company.

What is the current stock price of Shanghai YaKe Biotechnology Co., Ltd.?

Shanghai YaKe Biotechnology Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.

How much is Shanghai YaKe Biotechnology Co., Ltd. worth (valuation)?

Valuation information for Shanghai YaKe Biotechnology Co., Ltd. is not publicly available.

Can I buy Shanghai YaKe Biotechnology Co., Ltd. stock?

Shanghai YaKe Biotechnology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Shanghai YaKe Biotechnology Co., Ltd.'s last funding round?

Shanghai YaKe Biotechnology Co., Ltd.'s most recent funding round was Series A on May 1, 2016.

Who are the main investors in Shanghai YaKe Biotechnology Co., Ltd.?

Investor information for Shanghai YaKe Biotechnology Co., Ltd. is not publicly disclosed.

Will Shanghai YaKe Biotechnology Co., Ltd. IPO soon?

No public IPO plans have been announced for Shanghai YaKe Biotechnology Co., Ltd..

How can I track Shanghai YaKe Biotechnology Co., Ltd. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Shanghai YaKe Biotechnology Co., Ltd.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersShanghai
Employee Range3
Year Founded2011
Last FundingMay 1, 2016

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?